We are a Swiss pharmaceutical group providing solutions in more than 70 countries around the world.
TRB’s particular expertise lies above all in the production, packaging and therapeutic options relating to hyaluronic acid.
TRB CHEMEDICA MEA portfolio includes ophthalmological products as VISMED® – Hyaluronic Acid based eye drops and OSTENIL® – Intraarticular injections to treat post-traumatic and degenerative joint disease, such as osteoarthritis.
Company’s Keywords:
osteoarthritis, rheumatology, dry eye, opthalmology, hyaluronic acid
<0
<
<